Novartis, Others Can't Stop Generic Tobramycin Suit

Law360, New York (December 21, 2011, 8:37 PM EST) -- An Illinois federal judge on Tuesday denied an attempt by Novartis Pharmaceuticals Corp. and others to dismiss a suit they brought against Akorn Inc. over a patent for cystic fibrosis medication, finding that Akorn should still get a chance to have the patent declared invalid.

Despite a new agreement from plaintiffs Novartis, Seattle Children's Hospital, and Novartis Vaccines and Diagnostics Inc. not to sue Akron for infringement of the patent-in-suit, U.S. District Judge Robert M. Dow Jr., ruled that Akorn can move forward with an attempt...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.